Literature DB >> 17506690

Hyaluronan in tissue injury and repair.

Dianhua Jiang1, Jiurong Liang, Paul W Noble.   

Abstract

A hallmark of tissue injury and repair is the turnover of extracellular matrix components. This review focuses on the role of the glycosaminoglycan hyaluronan in tissue injury and repair. Both the synthesis and degradation of extracellular matrix are critical contributors to tissue repair and remodeling. Fragmented hyaluronan accumulates during tissue injury and functions in ways distinct from the native polymer. There is accumulating evidence that hyaluronan degradation products can stimulate the expression of inflammatory genes by a variety of immune cells at the injury site. CD44 is the major cell-surface hyaluronan receptor and is required to clear hyaluronan degradation products produced during lung injury; impaired clearance of hyaluronan results in persistent inflammation. However, hyaluronan fragment stimulation of inflammatory gene expression is not dependent on CD44 in inflammatory macrophages. Instead, hyaluronan fragments utilize both Toll-like receptor (TLR) 4 and TLR2 to stimulate inflammatory genes in macrophages. Hyaluronan also is present on the cell surface of lung alveolar epithelial cells and provides protection against tissue damage by interacting with TLR2 and TLR4 on these parenchymal cells. The simple repeating structure of hyaluronan appears to be involved in a number of important aspects of noninfectious tissue injury and repair that are dependent on the size and location of the polymer as well as the interacting cells. Thus, the interactions between the endogenous matrix component hyaluronan and its signaling receptors initiate inflammatory responses, maintain structural cell integrity, and promote recovery from tissue injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506690     DOI: 10.1146/annurev.cellbio.23.090506.123337

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  293 in total

1.  TLR2 activation inhibits embryonic neural progenitor cell proliferation.

Authors:  Eitan Okun; Kathleen J Griffioen; Tae Gen Son; Jong-Hwan Lee; Nicholas J Roberts; Mohamed R Mughal; Emmette Hutchison; Aiwu Cheng; Thiruma V Arumugam; Justin D Lathia; Henriette van Praag; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

Review 2.  Extracellular matrix dynamics and fetal membrane rupture.

Authors:  Jerome F Strauss
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

3.  Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells.

Authors:  Xinhai Wan; Jie Liu; Jing-Fang Lu; Vassiliki Tzelepi; Jun Yang; Michael W Starbuck; Lixia Diao; Jing Wang; Eleni Efstathiou; Elba S Vazquez; Patricia Troncoso; Sankar N Maity; Nora M Navone
Journal:  Clin Cancer Res       Date:  2012-02-01       Impact factor: 12.531

4.  Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.

Authors:  Mandana Veiseh; Daniel Breadner; Jenny Ma; Natalia Akentieva; Rashmin C Savani; Rene Harrison; David Mikilus; Lisa Collis; Stefan Gustafson; Ting-Yim Lee; James Koropatnick; Leonard G Luyt; Mina J Bissell; Eva A Turley
Journal:  Biomacromolecules       Date:  2011-12-12       Impact factor: 6.988

Review 5.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

6.  Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2010-07

7.  Biosimulation of inflammation and healing in surgically injured vocal folds.

Authors:  Nicole Y K Li; Yoram Vodovotz; Patricia A Hebda; Katherine Verdolini Abbott
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-06       Impact factor: 1.547

8.  Substrate-induced phenotypic switches of human smooth muscle cells: an in vitro study of in-stent restenosis activation pathways.

Authors:  Anna L Guildford; Helen J S Stewart; Christopher Morris; Matteo Santin
Journal:  J R Soc Interface       Date:  2010-11-24       Impact factor: 4.118

9.  Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.

Authors:  Souheil El-Chemaly; Daniela Malide; Enrique Zudaire; Yoshihiko Ikeda; Benjamin A Weinberg; Gustavo Pacheco-Rodriguez; Ivan O Rosas; Marta Aparicio; Ping Ren; Sandra D MacDonald; Hai-Ping Wu; Steven D Nathan; Frank Cuttitta; J Philip McCoy; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice.

Authors:  Jiurong Liang; Yanli Zhang; Ting Xie; Ningshan Liu; Huaiyong Chen; Yan Geng; Adrianne Kurkciyan; Jessica Monterrosa Mena; Barry R Stripp; Dianhua Jiang; Paul W Noble
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.